Induction of plasminogen activator inhibitor type 1 synthesis by cadmium in human vascular endothelial cells in culture

Journal of Health Science

Volumn 48, Issue 1, 2002, Pages 55-61

  Yamamoto, Chika ^a   Kaji, Toshiyuki ^a  

^a HOKURIKU UNIVERSITY   (Japan)

Author keywords

Cadmium; Endothelial cell; Fibrinolysis; Plasminogen activator inhibitor; Vascular

Indexed keywords

1 (5 ISOQUINOLINESULFONYL) 2 METHYLPIPERAZINE; CADMIUM CHLORIDE; DACTINOMYCIN; MESSENGER RNA; N (2 GUANIDINOETHYL) 5 ISOQUINOLINESULFONAMIDE; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN KINASE C; TISSUE PLASMINOGEN ACTIVATOR; UROKINASE;

ANALYTIC METHOD; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; FIBRIN ZYMOGRAPHY; HUMAN; HUMAN CELL; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UMBILICAL VEIN; VASCULAR ENDOTHELIUM; ZYMOGRAPHY;

EID: 23744442462     PISSN: 13449702     EISSN: None     Source Type: Journal    
DOI: 10.1248/jhs.48.55     Document Type: Article

References (40)

1. Levin, E. G. and Loskutoff, D. J. (1982) Cultured bovine aortic endothelial cells produce both urokinase and tissue-type plasminogen activators. J. Cell Biol., 94, 631-636.
2. Gross, J. L., Moscatelli, D., Jaffe, E. A. and Rifkin, D. B. (1982) Plasminogen activator and collagenase production by cultured capillary endothelial cells. J. Cell Biol., 95, 974-981.
3. Mourik, J. A. V., Lawrence, D. A. and Loskutoff, D. J. (1984) Purification of an inhibitor of plasminogen activator (antiactivator) synthesized by endothelial cells. J. Biol. Chem., 259, 14914-14921.
4. Hoylaert, M., Rijken, D. C., Lojnen, H. R. and Collen, D. (1982) Kinetics of the activation of plasminogen by human tissue plasminogen activator: role of fibrin. J. Biol. Chem., 257, 2912-2919.
5. Ranby, M. (1982) Studies on the kinetics of plasminogen activation by tissue plasminogen activator. Biochim. Biophys. Acta, 704, 461-469.
6. Houtman, J. P. (1993) Prolonged low-level cadmium intake and atherosclerosis. Sci. Total Environ., 138, 31-36.
7. Carroll, R. E. (1966) The relationship of cadmium in the air to cardiovascular disease death rates. J. Am. Med. Assoc., 198, 267-269.
8. Revis, N. W., Zinsmeister, A. R. and Bull, R. (1981) Atherosclerosis and hypertension induction by lead and cadmium ions: an effect prevented by calcium ion. Proc. Natl. Acad. Sci. U.S.A., 78, 6494-6498.
9. Subramanyan, G., Bhaskar, M. and Govindappa, S. (1992) The role of cadmium in induction of atherosclerosis in rabbits. Ind. Heart J., 44, 177-180.
10. Kaji, T., Yamamoto, C., Miyajima, S., Suzuki, M., Fujiwara, Y., Sakamoto, M. and Koizumi, F. (1995) Vascular smooth muscle cells in culture are highly sensitive to cadmium cytotoxicity without speciesrelated differences: comparison with Chang liver cells. Biol. Pharm. Bull., 18, 1392-1395.
11. Kaji, T., Suzuki, M., Yamamoto, C., Imaki, Y., Miyajima, S., Fujiwara, Y., Sakamoto, M. and Kozuka, H. (1996) Sensitive response of cultured vascular smooth-muscle cells to cadmium cytotoxicity: comparison with cultured vascular endothelial cells and kidney epithelial LLC-PK1 cells. Toxicol. Lett., 89, 131-137.
12. Kaji, T., Mishima, A., Yamamoto, C., Sakamoto, M. and Koizumi, F. (1992) Effect of cadmium on the monolayer maintenance of vascular endothelial cells in culture. Toxicology, 71, 267-276.
13. Fujiwara, Y., Watanabe, S. and Kaji, T. (1998) Promotion of cultured vascular smooth muscle cell proliferation by low levels of cadmium. Toxicol. Lett., 94, 175-180.
14. Schneiderman, J., Sawdey, M. S., Keeton, M. R., Bordin, G. M., Bernstein, E. F., Dilley, R. B. and Loskutoff, D. J. (1992) Increased type 1 plasminogen activator inhibitor gene expression in atherosclerotic human arteries. Proc. Natl. Acad. Sci. U.S.A., 89, 6998-7002.
15. Robbie, L. A., Booth, N. A., Brown, A. J. and Bennett, B. (1996) Inhibitors of fibrinolysis are elevated in atherosclerotic plaque. Arterioscler. Thromb. Vasc. Biol., 16, 539-545.
16. Shireman, P. K., McCarthy, W. J., Pearce, W. H., Patterson, B. K., Shively, V. P., Cipollone, M., Tamarina, N., Verrusio, E. N. and Kwaan, H. C. (1996) Elevated levels of plasminogen-activator inhibitor type 1 in atherosclerotic aorta. J. Vasc. Surg., 23, 810-818.
17. Padro, T., Steins, M., Li, C. X., Mesters, R. M., Hammel, D., Scheld, H. H. and Kienast, J. (1997) Comparative analysis of plasminogen activator inhibitor-1 expression in different types of atherosclerotic lesions in coronary arteries from human heart explants. Cardiovasc. Res., 36, 28-36.
18. Eitzman, D. T., Westrick, R. J., Tyson, J. and Ginsburg, D. (2000) Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery. Blood, 96, 4212-4215.
19. Zhu, Y., Farrehi, P. M. and Fay, W. P. (2000) Plasminogen activator inhibitor type 1 enhances neointima formation after oxidative vascular injury in atherosclerosis-prone mice. Circulation, 103, 3105-3110.
20. Yamamoto, C., Kaji, T., Sakamoto, M. and Kozuka, H. (1993) Cadmium stimulation of plasminogen activator inhibitor-1 release from human vascular endothelial cells in culture. Toxicology, 83, 215-223.
21. Matsuo, C., Fukao, H. and Matsuo, O. (1988) Characterization of plasminogen activator produced by an established cell line from human ovary. J. Cell. Physiol., 134, 253-260.
22. Ninomiya, I., Endo, Y., Yonemura, Y., Noguchi, M., Fushida, S., Nakai, M., Takemura, H., Harada, F., Suzuki, T., Miyazaki, I. and Sasaki, T. (1992) Spe-cific detection of c-erbB-2 mRNA expression in gastric cancers by the polymerase chain reaction following reverse transcription. Br. J. Cancer, 66, 84-87.
23. Onosaka, S., Tanaka, K., Doi, M. and Okahara, K. (1978) A simplified procedure for determination of metallothionein in animal tissues. Jpn. J. Toxicol. Environ. Health, 24, 128-131.
24. Kissane, J. M. and Robins, E. (1958) The fluorometric measurement of deoxyribonucleic acid in animal tissue with special reference to the central nervous system. J. Biol. Chem., 233, 184-188.
25. Kooistra, T., Bosma, P. J., Toet, K., Cohen, L. H., Griffioen, M., ven den Berg, E., Clercq, L. L. and van Hinsberg, V. W. M. (1991) Role of protein kinase C and cyclic adenosine monophosphate in the regulation of tissue-type plasminogen activator, plasminogen activator inhibitor-1 and platelet-derived growth factor mRNA levels in human endothelial cells. Possible involvement of proto-oncogenes cjun and c-fos. Atheroscler. Thromb., 11, 1042-1052.
26. Grulich-Henn, J. and Müller-Burghause, G. (1990) Regulation of endothelial tissue plasminogen activator and plasminogen activator inhibitor type 1 synthesis by diacylglycerol, phorbol ester and thrombin. Blut, 61, 38-44.
27. Wun, T. C., Schleuning, W. D. and Reich, E. (1982) Isolation and characterization of urokinase from human plasma. J. Biol. Chem., 257, 3276-3283.
28. 2+-induced cmyc mRNA accumulation in NRK-49F cells is blocked by the protein kinase inhibitor H7 but not by HA1004, indicating that protein kinase C is a mediator of the response. Toxicology, 81, 155-164.
29. Block, C., Freyermuth, S., Beyersmann, D. and Malviya, A. N. (1992) Role of cadmium in activating nuclear protein kinase C and the enzyme binding to nuclear protein. J. Biol. Chem., 267, 19824-19828.
30. Long, G. J. (1997) The effect of cadmium on cytosolic free calcium, protein kinase C, and collagen synthesis in rat osteosarcoma (ROS 17/2.8) cells. Toxicol. Appl. Pharmacol., 143, 189-195.
31. Bagchi, D., Bagchi, M., Tang, L. and Stohs, S. J. (1997) Comparative in vitro and in vivo protein kinase C activation by selected pesticides and transition metal salts. Toxicol. Lett., 91, 31-37.
32. Speizer, L. A., Watson, M. J., Kanter, J. R. and Brunton, L. L. (1989) Inhibition of phorbol ester binding and protein kinase C activity by heavy metals. J. Biol. Chem., 264, 5581-5585.
33. Erickson, L. A., Schleef, R. R., Ny, T. and Loskutoff, D. J. (1985) The fibrinolytic system of the vascular wall. Clin. Haematol., 40, 185-190.
34. Hanss, M. and Collen, D. (1987) Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by human endothelial cells: modulation by thrombin endotoxin and histamine. J. Lab. Clin. Med., 109, 97-104.
35. Fujiwara, Y. and Kaji, T. (2000) Inhibition of the repair of injured endothelial cell monolayers by lead and its possible mechanisms. J. Health Sci., 46, 1-4.
36. Kaji, T., Fujiwara, Y., Hoshino, M., Yamamoto, C., Sakamoto, M. and Kozuka, H. (1995) Inhibitory effect of lead on the proliferation of cultured vascular endothelial cells. Toxicology, 95, 87-92.
37. Yamamoto, C. and Kaji, T. (1999) Effect of lead on the synthesis of tissue plasminogen activator by vascular endothelial cells in culture. J. Health Sci., 45, 119-125.
38. Kaji, T., Yamamoto, C., Sakamoto, M. and Kozuka, H. (1992) Inhibitory effect of lead on the release of tissue plasminogen activator from human vascular endothelial cells in culture. Toxicology, 73, 219-227.
39. Yamamoto, C., Kaji, T., Sakamoto, M. and Kozuka, H. (1996) Effects of cadmium on the release of tissue plasminogen activator and plasminogen activator inhibitor type 1 from human vascular smooth muscle cells and fibroblasts. Toxicology, 106, 179-185.
40. Yamamoto, C., Miyamoto, A., Sakamoto, M., Kaji, T. and Kozuka, H. (1997) Lead perturbs the regulation of spontaneous release of tissue plasminogen activator and plasminogen activator inhibitor-1 from vascular smooth muscle cells and fibroblasts in culture. Toxicology, 117, 153-161.